Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Vaccinations01:51

Vaccinations

Overview
Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Choosing the Right Extracellular Vesicle: Cross-Kingdom Immunological Functions Linking Molecular Mechanisms to Therapeutic Applications.

Biomolecules·2026
Same author

A non-conjugated peptide-adjuvant system of synthetic peptide-vaccine elicited potent antibody response and opsonic protection against clinical GAS strains.

Bioorganic chemistry·2026
Same author

Rational selection of antigenic targets for Group A Streptococcus vaccine: updates, challenges and opportunities.

NPJ vaccines·2026
Same author

Veterinary Forensic Pathology in the Investigation of Animal Cruelty: Post-Mortem Insights, Forensic Tools, Case Studies, and Legal Perspectives.

Animals : an open access journal from MDPI·2026
Same author

The Collaborative Collapse: Bile Acid Dysmetabolism as a Central Pathogenic Driver in Canine and Feline Multi-Systemic Disorders-From Mechanisms to Precision Therapeutics.

Veterinary sciences·2026
Same author

Development of a Novel Polyleucine-Based Immunopotentiator for Subunit Vaccines Against Group A Streptococcus.

Small (Weinheim an der Bergstrasse, Germany)·2026

Related Experiment Video

Updated: Jul 7, 2026

Cellular Affinity of Particle-Stabilized Emulsion to Boost Antigen Internalization
10:06

Cellular Affinity of Particle-Stabilized Emulsion to Boost Antigen Internalization

Published on: September 2, 2022

Self-adjuvanting lipopeptide vaccines.

Peter M Moyle1, Istvan Toth

  • 1School of Molecular and Microbial Sciences and School of Pharmacy, the University of Queensland, St Lucia 4072, QLD, Australia. pmoyle@mail.rockefeller.edu

Current Medicinal Chemistry
|February 22, 2008
PubMed
Summary

Self-adjuvanting lipopeptide vaccines offer a safer, more effective alternative to traditional adjuvants. These novel vaccines can be administered mucosally, enhancing immune responses with minimal toxicity.

More Related Videos

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses
06:02

Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses

Published on: February 23, 2024

Related Experiment Videos

Last Updated: Jul 7, 2026

Cellular Affinity of Particle-Stabilized Emulsion to Boost Antigen Internalization
10:06

Cellular Affinity of Particle-Stabilized Emulsion to Boost Antigen Internalization

Published on: September 2, 2022

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses
06:02

Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses

Published on: February 23, 2024

Area of Science:

  • Vaccinology
  • Immunology
  • Medicinal Chemistry

Background:

  • Traditional vaccine adjuvants often exhibit high toxicity, limiting their clinical application and hindering vaccine development.
  • Few adjuvants have been successfully incorporated into human vaccines due to safety concerns, impacting the creation of new vaccines and improvement of existing ones.

Purpose of the Study:

  • To review and categorize extensively studied lipopeptide vaccine systems.
  • To discuss the mechanisms of action, structure-activity relationships, and applications of various lipopeptide and glycolipopeptide vaccine formulations.

Main Methods:

  • Categorization of lipopeptide vaccine systems into bacterial lipopeptides (Pam3Cys, Pam2Cys), lipid-core peptide (LCP) and multiple antigen lipophilic adjuvant carrier (MALAC) systems, single-chain palmitoylated peptides, and glycolipids (monophosphoryl lipid A).
  • Review of existing literature on lipopeptide vaccine systems, including their conjugation methods, administration routes, and immune responses elicited.
  • Analysis of potential mechanisms of action and structure-activity relationships.

Main Results:

  • Lipopeptide vaccines demonstrate advantages over traditional adjuvants like alum salts, including mucosal administration feasibility (oral, nasal), induction of antigen-specific cytotoxic T-lymphocytes, and mucosal immunity.
  • These self-adjuvanting systems exhibit significantly reduced toxicity compared to many experimental adjuvants.
  • Various lipopeptide systems, from single fatty acid chains to complex lipids and glycolipids conjugated to peptide antigens, have shown promise in preclinical and clinical studies.

Conclusions:

  • Self-adjuvanting lipopeptide vaccines represent a promising platform for developing safer and more effective vaccines.
  • Their ability to induce robust cellular and mucosal immunity via non-invasive routes offers a significant advancement in vaccinology.
  • Further research into lipopeptide and glycolipopeptide systems holds potential for addressing unmet needs in infectious disease prevention and improving current vaccine strategies.